Enhanced susceptibility to low‐dose collagen‐induced arthritis in CR1/2‐deficient female mice—possible role of estrogen on CR1 expression

No abstract is available for this paper.

• Publication year

  2009

• Venue

  The FASEB Journal

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.08-125849PMID 19351702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.

  2008cited by this paper
• Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.

  2008cited by this paper
• Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells

  2006cited by this paper
• Rheumatoid factor on a daily basis

  2005cited by this paper
• A Critical Role for Complement C3d and the B Cell Coreceptor (CD19/CD21) Complex in the Initiation of Inflammatory Arthritis1

  2005cited by this paper
• Hormonal modulation of B cell development and repertoire selection.

  2005cited by this paper
• IgG Fc receptor polymorphisms and association with autoimmune disease

  2005cited by this paper
• Regulation of B-cell activation by complement receptors CD21 and CD35.

  2003cited by this paper
• A Role for Complement in Feedback Enhancement of Antibody Responses by IgG3

  2003cited by this paper
• Induction of arthritis by single monoclonal IgG anti‐collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcγRIIB

  2003cited by this paper
• Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation.

  2002cited by this paper
• Hormones, pregnancy, and rheumatoid arthritis.

  2002cited by this paper
• Complement and systemic lupus erythematosus

  2002cited by this paper
• Estrogen alters thresholds for B cell apoptosis and activation.

  2002cited by this paper
• Complement Receptor Type 1 (CD35) Mediates Inhibitory Signals in Human B Lymphocytes1

  2002cited by this paper
• Complement Deficiency Ameliorates Collagen-Induced Arthritis in Mice1

  2002cited by this paper
• Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage.

  2001cited by this paper
• Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen‐induced arthritis

  2000cited by this paper
• A Role for Complement in Antibody-Mediated Inflammation: C5-Deficient DBA/1 Mice Are Resistant to Collagen-Induced Arthritis

  2000cited by this paper
• Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis.

  2000cited by this paper
• Antibody Production in Mice Deficient for Complement Receptors 1 and 2 Can Be Induced by IgG/Ag and IgE/Ag, But Not IgM/Ag Complexes1

  2000cited by this paper
• Complement activation and inhibition in experimental models of arthritis.

  1999cited by this paper
• Interaction with Complement Receptor 1 (CD35) Leads to Amelioration of Sepsis‐Triggered Mortality but Aggravation of Arthritis During Staphylococcus aureus Infection

  1999cited by this paper
• Estrogen-mediated immunosuppression in autoimmune diseases

  1998cited by this paper
• A critical role for complement in maintenance of self-tolerance.

  1998cited by this paper
• B cell‐deficient mice do not develop type II collagen‐induced arthritis (CIA)

  1998cited by this paper
• The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2).

  1997cited by this paper
• Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.

  1997cited by this paper
• Antibody response to a T-dependent antigen requires B cell expression of complement receptors

  1996cited by this paper
• Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.

  1996cited by this paper
• C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity

  1996cited by this paper
• Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

  1996cited by this paper
• Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.

  1995cited by this paper
• Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.

  1995cited by this paper
• Acute inflammatory polyarthritis in association with tamoxifen.

  1994cited by this paper
• Acute inflammatory polyarthritis in association with tamoxifen.

  1994cited by this paper
• Lowered expression of C3b receptor (CR1) on erythrocytes of rheumatoid arthritis patients.

  1994cited by this paper
• Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.

  1994cited by this paper
• Oestrogen‐induced suppression of collagen arthritis; 17β‐oestradiol is therapeutically active in normal and castrated F1 hybrid mice of both sexes

  1992cited by this paper
• Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.

  1991cited by this paper
• Suppression of the immune response by a soluble complement receptor of B lymphocytes.

  1991cited by this paper
• In vivo inhibition of the antibody response by a complement receptor- specific monoclonal antibody

  1990cited by this paper
• Estrogen induced suppression of collagen arthritis. V: Physiological level of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T-cell dependent immunity and stimulates polyclonal B-cell activity.

  1990cited by this paper
• The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1.

  1990cited by this paper
• Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis.

  1990cited by this paper
• Type II collagen-induced murine arthritis

  1990cited by this paper
• Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.

  1988cited by this paper
• Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.

  1988cited by this paper
• Complement deficiency: predisposing factor to autoimmune syndromes.

  1988cited by this paper
• Oestrogen‐Induced Suppression of Collagen Arthritis

  1987cited by this paper
• Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.

  1986cited by this paper
• Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II.

  1985cited by this paper
• Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci

  1985cited by this paper
• Type II Collagen‐induced Arthritis

  1985cited by this paper
• Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen.

  1984cited by this paper
• Serum transfer of collagen-induced arthritis in mice

  1983cited by this paper
• Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin.

  1983cited by this paper
• Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

  1981cited by this paper
• Studies on type II collagen induced polyarthritis in rats. Effect of complement depletion.

  1981cited by this paper
• Immunisation against heterologous type II collagen induces arthritis in mice

  1980cited by this paper
• ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO

  1974cited by this paper
• Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin.

  1972cited by this paper
• A SINGLE GENE CONTROLLING HEMOLYTIC COMPLEMENT AND A SERUM ANTIGEN IN THE MOUSE.

  1964cited by this paper

• Association Between the Use of Oral Contraceptives and the Development of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

  2025cites this paper
• Hormones and B-cell development in health and autoimmunity

  2024cites this paper
• Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis

  2021cites this paper
• Marginal zone B cells: From housekeeping function to autoimmunity?

  2021cites this paper
• The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models

  2019cites this paper
• Inhibiting the Cannabinoid Catabolic Enzyme MAGL to Potentiate the Anti-Arthritic Properties of the Synthetic Glucocorticoid Dexamethasone

  2017cites this paper
• Regulation of B cell functions by Toll-like receptors and complement.

  2016cites this paper
• The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).

  2016cites this paper
• Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis

  2015cites this paper
• Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients

  2014cites this paper
• Expression and function of complement- and Toll-like receptors in human B cells under physiological and autoimmune conditions -linking innate and adaptive immunity

  2014cites this paper
• Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.

  2013cites this paper
• Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5

  2013cites this paper
• Endogenous estrogen regulation of inflammatory arthritis and cytokine expression in male mice, predominantly via estrogen receptor alpha.

  2010cites this paper
• Down regulation of Fc and complement receptors on B cells in rheumatoid arthritis.

  2010cites this paper
• The Role of Complement Receptors and Fc gamma Receptor IIb in Collagen-induced Arthritis

  2010cites this paper
• Marginal Zone B Cells Are Naturally Reactive to Collagen Type Ii and Initiate the Immune Response in Collagen-induced Arthritis Manuscript in Submission

  year unknowncites this paper